Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates
Exploring the Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates
2 other identifiers
observational
57
1 country
1
Brief Summary
This study will look at how people cope with an upcoming bone marrow transplant and how personality characteristics influence coping styles in stressful medical situations. Personality traits, such as extraversion, optimism and self-esteem have been related to active, problem-focused coping styles, whereas neuroticism has been related to increased psychological distress and denial as a way of coping. Coping styles, in turn, have been related to disease outcome. For example, a fighting spirit and avoidance have been correlated with longer survival, whereas fatalism, anxious preoccupation and feelings of helplessness and hopelessness were related to a poor disease outcome. A better understanding of the relationship between coping styles and personality may help improve supportive care for people undergoing bone marrow transplants. This study will:
- Explore the relationship between personality traits, coping styles and psychological stress in patients awaiting bone marrow transplantation
- Identify what coping styles people use to prepare for bone marrow transplantation
- Identify what personality traits are related to particular coping styles in patients awaiting bone marrow transplantation
- Identify the relationship between personality factors and level of psychological distress in patients awaiting bone marrow transplantation Cancer patients 18 years of age and older who are scheduled for bone marrow transplant are eligible for this study. Participants will fill out pencil-and-paper questionnaires providing demographic information (such as age, gender, marital status, ethnicity, and so forth) and answering questions about their opinions and preferences. The information will be used to assess the participants' personality characteristics, coping styles, and psychological distress. The questionnaires take about 45 to 50 minutes to complete.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2002
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2002
CompletedFirst Submitted
Initial submission to the registry
October 28, 2002
CompletedFirst Posted
Study publicly available on registry
October 29, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2005
CompletedMarch 4, 2008
September 1, 2005
October 28, 2002
March 3, 2008
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- All patients with diagnosis of cancer and awaiting BMT.
- Criteria for participation in the study include a diagnosis of cancer and being actively screened for a CC approved PBSC transplant protocol. The participants will not have undergone the transplant at the time of the evaluation. Participants will be ages 18 and older.
You may not qualify if:
- No patients who meet the eligibility criteria will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center (CC)
Bethesda, Maryland, 20892, United States
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
October 28, 2002
First Posted
October 29, 2002
Study Start
October 1, 2002
Study Completion
September 1, 2005
Last Updated
March 4, 2008
Record last verified: 2005-09